UiPath (NYSE:PATH – Free Report) had its price target cut by Canaccord Genuity Group from $19.00 to $14.00 in a research ...

UiPath (NYSE:PATH – Get Free Report) had its target price decreased by investment analysts at Mizuho from $14.00 to $12.00 in ...

UiPath (PATH) has seen its stock hit an all-time low following a bleak revenue forecast issued as a part of its Q4 FY 2025 financial results.

ARK also bought 79,201 shares of IBOTTA INC (NASDAQ:IBTA) across its ARKW and ARKF ETFs, with a total value of approximately $3.17 million. Notably, this purchase adds to ARK’s ongoing accumulation of ...

BMO Capital analyst Keith Bachman lowered the firm’s price target on UiPath (PATH) to $11.50 from $16 and keeps a Market Perform rating on the ...

UiPath (NYSE:PATH) saw its stock plummet over 14% intra-day today after delivering a disappointing revenue forecast for ...

The U.S. market has been on the back foot since the middle of February, as President Donald Trump’s tariff policy has sunk ...

The semiconductor company named Lip-Bu Tan, a former board m ...

Learn more about whether Manhattan Associates, Inc. or UiPath Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Learn more about whether Open Text Corporation or UiPath Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

The Dow, S&P 500, and Nasdaq fell Thursday as the stock market digested the latest economic data and Trump's response to Canada and EU tariffs. The S&P 500 closed in correction territory.

UiPath's growth slows to a crawl as it chases agentic AI dream with Peak acquisition, and its stock falls sharply - SiliconANGLE ...